GE Healthcare announced the US Food and Drug Administration (FDA) has approved DaTscan (Ioflupane I 123 Injection), a radiopharmaceutical agent intended for use with Single Photon Emission Computed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results